{"url_path":"/sec/mdt/8-k/2026-04-27/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1613103/0001628280-26-027272-index.html","accession_number":"0001628280-26-027272","cik":"0001613103","ticker":"MDT","issuer_name":"Medtronic plc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1613103/0001628280-26-027272-index.html","primary_entity_key":"0001613103","primary_entity_name":"Medtronic plc"},"word_count":75,"has_tables":true,"body_markdown":"Item 9.01.Exhibits.\n\n(d) List of Exhibits\n\nExhibit NumberDescription\n\n[99.1](exhibit991-statementdateda.htm)\n\n[Statement dated April 24, 2026, issued by Medtronic plc.](exhibit991-statementdateda.htm)\n\n104Cover Page Interactive Data File (embedded with the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nMedtronic plc\n\nDate: April 24, 2026By/s/ Michelle Quinn\n\nMichelle Quinn\n\nExecutive Vice President, General Counsel"}